Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer

International Journal of Cancer

Volumn 120, Issue 11, 2007, Pages 2452-2458

  Moore, Lee E ^a   Malats, Núria ^b   Rothman, Nathaniel ^a   Real, Francisco X ^b,c   Kogevinas, Manolis ^b   Karami, Sara ^a   García Closas, Reina ^d   Silverman, Debra ^a   Chanock, Stephen ^a   Welch, Robert ^a   Tardón, Adonina ^e   Serra, Consol ^c,f   Carrato, Alfredo ^g   Dosemeci, Mustafa ^a   García Closas, Montserrat ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

^f Hospital Universitari Parc Taulí   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Bladder cancer; CTH; Folate metabolism; Genetic susceptibility; GSTM1; One carbon metabolism

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; GLUTATHIONE TRANSFERASE; PYRIDOXINE; RIBOFLAVIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARBON METABOLISM; CBS GENE; CTH GENE; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUTATHIONE METABOLISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; MTR GENE; MTRR GENE; PRIORITY JOURNAL; SHMT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC19A1 GENE; TYMS GENE; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CARBON; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SULFUR; URINARY BLADDER NEOPLASMS;

EID: 34247326362     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22565     Document Type: Article

References (32)

1. Mason JB, Choi SW. Folate carcinogenesis: developing a unifying hypothesis. Adv Enzyme Regul 2000;40:127-41.
2. Larsson SC, Hakansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 2006;98:407-13.
3. Stevens VL, Rodriguez C, Pavluck AL, McCullough ML, Thun MJ, Calle EE. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006;163:989-96.
4. Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delchos GL, Grossman HB, Wu X. Nutr Cancer 2006;53:144-51.
5. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004;159:423-43.
6. Garcia-Closas R, Garcia-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, Tardon A, Carrato A, Castano-Vinyals G, Dosemeci M, Moore L, Rothman N, Sinha R. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer (submitted).
7. Silverman DT, Devesa SS, Moore LE, Rothman N. Bladder cancer. In: Schottenfeld D, Fraumeni JF, Jr, eds. Cancer epidemiology and prevention, 3rd edn. New York, NY: Oxford University Press, 2006. 1101-1127.
8. World Cancer Research Fund and American Institute for Cancer Research Food, nutrition, and the prevention of cancer. A global perspective. Washington DC: American Institute for Cancer Research, 1997.
9. Steinmaus CM, Nunez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 2000; 151:693-702.
10. Zeegers MP, Goldbohm RA, van den Brandt PA. Consumption of vegetables and fruits and urothelial cancer incidence: a prospective study. Cancer Epidemiol Biomarkers Prev 2001;10:1121-8.
11. Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D. Intakes of fruits and vegetables carotenoids and vitamins A, E, and C in relation to the risk of bladder cancer in the ATBC cohort study. Br J Cancer 2002;87:960-5.
12. Choi SW, Friso S. Interactions between folate and aging for carcinogenesis. Clin Chem Lab Med 2005;43:1151-7.
13. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. A second common mutation in the methyleletetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51.
14. Parle-McDermott A, Mills JL, Molloy AM, Carroll N, Kirke PN, Cox C, Conley MR, Pangilinan FJ, Brody LC, Scott JM. The MTHFR 1298 and 677 TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab 2006;88:290-4.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-13.
16. Wang J, Hegele RA. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine γ-lyase (CTH). Hum Genet 2003;112:404-8.
17. Wang J, Huff AM, Spence JD, Hegele RA. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clin Genet 2004;65:483-6.
18. Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 2004;25:1639-47.
19. Kim YI. 5,10 Methylenetetrahydrofolate reductase polymorphisms and pharmacogenetics: a new role of single nucleotide polymorphisms in the folate metabolic pathway in human health and disease. Nutr Rev 2005;63:398-407.
20. Heijmans BT, Boer JM, Suchiman HED, Cornelisse CJ, Westendorp RGJ, Kromhout D, Feskens EJM, Slagboom PE. A common variant of the methylenetetrahydrofolate reductase (1p36) is associated with increased risk of cancer. Cancer Res 2003;63:1249-53.
21. Moore LE, Wiencke JK, Bates MN, Zheng S, Rey OA, Smith AH. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 2004;211:197-207.
22. Kimura F, Florl AR, Steinhoff C, Golka K, Willers R, Seifert H, Schulz WA. Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 2001;458:49-54.
23. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkstrom H, Larsson P, Kumar R, Hemminki K. Polymorphsims in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-34.
24. Karagas MR, Parks S, Nelson HH, Andrew AS, Mott L, Schned A, Kelsey KT. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population based case-control study. Int J Hyg Environ Health 2005;208:321-7.
25. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Castano-Vinyals G, et al. NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-59.
26. Garcia-Closas M, Rothman N, Malats N, Real FX, Welch R, Yeager M, Silverman D, Kogevinas M, Dosemeci M, Tardon A, Serra C, Carrato A, et al. Large-scale evaluation of candidate genes for urinary bladder cancer susceptibility using Illumina® in the Spanish Bladder Cancer Study. 97th AACR Annual Meeting. Proc Am Assoc Cancer Res 2006;47: Abstract 2328.
27. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for associations between traits and haplotypes when linkage phase between traits is ambiguous. Am J Hum Genet 2002;70:425-34.
28. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
29. Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr 2006;136 (Suppl):1636S-1640S.
30. Stipanuk MH, Dominy JE, Lee JI, Coloso RM. Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr 2006;136 (Suppl):1652S-1659S.
31. Vitvitsky V, Mosharov E, Tritt M, Ataullakhanov F, Banerjee R. Redox regulation of homocysteine-dependent glutathione synthesis. Redox Rep 2003;8:57-63.
32. Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156:95-109.